Cost Plus Arbitrage Dataset
收藏官方服务：
资源简介：
A cross-referenced dataset comparing Mark Cuban Cost Plus Drugs' generic drug prices against what U.S. Medicare Part D and state Medicaid programs paid for the same drugs, enriched with independently-sourced, publicly-documented pharmacy benefit manager (PBM) markup figures drawn from federal studies, a state-mandated price-transparency report, a peer-reviewed academic study, and federal court litigation exhibits. This is a point-in-time snapshot (data accessed 2026-07-16, NADAC effective date 2026-07-15) -- re-running the pipeline against current CMS data will produce different figures. See dataset/README.md and dataset/PROVENANCE.md for full documentation.
提供机构：
Zenodo创建时间：
2026-07-17
